Abnormal cardiocoronary thromboxane A2 production in patients with unstable angina

Gian Gastone Neri Serneri, Gian Franco Gensini, Rosanna Abbate, Domenico Prisco, Pier Giorgio Rogasi, Raffaele Laureano, Gian Carlo Casolo, Fabio Fantini, Marisa Di Donato, Roberto Piero Dabizzi

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Thromboxane B2 (TXB2), the stable metabolite of thromboxane A2 (TXA2), was measured in the coronary sinus and in aortic blood before and after cold pressor test (CPT) in 21 patients suffering from ischemic heart disease (7 affected by stable effort angina and 14 by unstable angina) and in 12 patients not suffering from myocardial ischemia (control group) during coronary angiography. Aspirin (10 mg/kg intravenously) was administered before catheterization in order to prevent platelet and leukocyte TXA2 formation. Control subjects and patients with effort angina had TXB2 resting levels lower than unstable angina patients without a transcardiac gradient which, on the contrary, was found in unstable angina patients. Only in these patients CPT resulted in a significant TXB2 increase more marked in the coronary sinus (from 50.0 ± 18.9 pg/ml to 73.0 ± 35.1 pg/ml, p <0.001) than in the aorta (from 33.4 ± 17.1 pg/ml to 42.6 ± 24.0 pg/ml, p <0.05), so that the transcardiac TXB2 gradient significantly increased. In all but two unstable angina patients, TXB2 elevation was not associated with a fall of cardiac lactate extraction. The resting and CPT-induced TXB2 gradients were unrelated to the presence and severity of coronary angiographic lesions. These results indicate that unstable angina patients show an abnormal cardiocoronary capacity to synthesize TXA2, which seems not to be elicited by the occurrence of myocardial ischemia.

Original languageEnglish
Pages (from-to)732-738
Number of pages7
JournalAmerican Heart Journal
Volume109
Issue number4
DOIs
Publication statusPublished - 1985

Fingerprint

Thromboxane A2
Unstable Angina
Thromboxane B2
Myocardial Ischemia
Coronary Sinus
Stable Angina
Coronary Angiography
Catheterization
Aspirin
Aorta
Lactic Acid
Leukocytes
Blood Platelets
Control Groups

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Neri Serneri, G. G., Gensini, G. F., Abbate, R., Prisco, D., Rogasi, P. G., Laureano, R., ... Dabizzi, R. P. (1985). Abnormal cardiocoronary thromboxane A2 production in patients with unstable angina. American Heart Journal, 109(4), 732-738. https://doi.org/10.1016/0002-8703(85)90631-3

Abnormal cardiocoronary thromboxane A2 production in patients with unstable angina. / Neri Serneri, Gian Gastone; Gensini, Gian Franco; Abbate, Rosanna; Prisco, Domenico; Rogasi, Pier Giorgio; Laureano, Raffaele; Casolo, Gian Carlo; Fantini, Fabio; Donato, Marisa Di; Dabizzi, Roberto Piero.

In: American Heart Journal, Vol. 109, No. 4, 1985, p. 732-738.

Research output: Contribution to journalArticle

Neri Serneri, GG, Gensini, GF, Abbate, R, Prisco, D, Rogasi, PG, Laureano, R, Casolo, GC, Fantini, F, Donato, MD & Dabizzi, RP 1985, 'Abnormal cardiocoronary thromboxane A2 production in patients with unstable angina', American Heart Journal, vol. 109, no. 4, pp. 732-738. https://doi.org/10.1016/0002-8703(85)90631-3
Neri Serneri GG, Gensini GF, Abbate R, Prisco D, Rogasi PG, Laureano R et al. Abnormal cardiocoronary thromboxane A2 production in patients with unstable angina. American Heart Journal. 1985;109(4):732-738. https://doi.org/10.1016/0002-8703(85)90631-3
Neri Serneri, Gian Gastone ; Gensini, Gian Franco ; Abbate, Rosanna ; Prisco, Domenico ; Rogasi, Pier Giorgio ; Laureano, Raffaele ; Casolo, Gian Carlo ; Fantini, Fabio ; Donato, Marisa Di ; Dabizzi, Roberto Piero. / Abnormal cardiocoronary thromboxane A2 production in patients with unstable angina. In: American Heart Journal. 1985 ; Vol. 109, No. 4. pp. 732-738.
@article{6363963ec6fe4f7290c457740c5faea2,
title = "Abnormal cardiocoronary thromboxane A2 production in patients with unstable angina",
abstract = "Thromboxane B2 (TXB2), the stable metabolite of thromboxane A2 (TXA2), was measured in the coronary sinus and in aortic blood before and after cold pressor test (CPT) in 21 patients suffering from ischemic heart disease (7 affected by stable effort angina and 14 by unstable angina) and in 12 patients not suffering from myocardial ischemia (control group) during coronary angiography. Aspirin (10 mg/kg intravenously) was administered before catheterization in order to prevent platelet and leukocyte TXA2 formation. Control subjects and patients with effort angina had TXB2 resting levels lower than unstable angina patients without a transcardiac gradient which, on the contrary, was found in unstable angina patients. Only in these patients CPT resulted in a significant TXB2 increase more marked in the coronary sinus (from 50.0 ± 18.9 pg/ml to 73.0 ± 35.1 pg/ml, p <0.001) than in the aorta (from 33.4 ± 17.1 pg/ml to 42.6 ± 24.0 pg/ml, p <0.05), so that the transcardiac TXB2 gradient significantly increased. In all but two unstable angina patients, TXB2 elevation was not associated with a fall of cardiac lactate extraction. The resting and CPT-induced TXB2 gradients were unrelated to the presence and severity of coronary angiographic lesions. These results indicate that unstable angina patients show an abnormal cardiocoronary capacity to synthesize TXA2, which seems not to be elicited by the occurrence of myocardial ischemia.",
author = "{Neri Serneri}, {Gian Gastone} and Gensini, {Gian Franco} and Rosanna Abbate and Domenico Prisco and Rogasi, {Pier Giorgio} and Raffaele Laureano and Casolo, {Gian Carlo} and Fabio Fantini and Donato, {Marisa Di} and Dabizzi, {Roberto Piero}",
year = "1985",
doi = "10.1016/0002-8703(85)90631-3",
language = "English",
volume = "109",
pages = "732--738",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Abnormal cardiocoronary thromboxane A2 production in patients with unstable angina

AU - Neri Serneri, Gian Gastone

AU - Gensini, Gian Franco

AU - Abbate, Rosanna

AU - Prisco, Domenico

AU - Rogasi, Pier Giorgio

AU - Laureano, Raffaele

AU - Casolo, Gian Carlo

AU - Fantini, Fabio

AU - Donato, Marisa Di

AU - Dabizzi, Roberto Piero

PY - 1985

Y1 - 1985

N2 - Thromboxane B2 (TXB2), the stable metabolite of thromboxane A2 (TXA2), was measured in the coronary sinus and in aortic blood before and after cold pressor test (CPT) in 21 patients suffering from ischemic heart disease (7 affected by stable effort angina and 14 by unstable angina) and in 12 patients not suffering from myocardial ischemia (control group) during coronary angiography. Aspirin (10 mg/kg intravenously) was administered before catheterization in order to prevent platelet and leukocyte TXA2 formation. Control subjects and patients with effort angina had TXB2 resting levels lower than unstable angina patients without a transcardiac gradient which, on the contrary, was found in unstable angina patients. Only in these patients CPT resulted in a significant TXB2 increase more marked in the coronary sinus (from 50.0 ± 18.9 pg/ml to 73.0 ± 35.1 pg/ml, p <0.001) than in the aorta (from 33.4 ± 17.1 pg/ml to 42.6 ± 24.0 pg/ml, p <0.05), so that the transcardiac TXB2 gradient significantly increased. In all but two unstable angina patients, TXB2 elevation was not associated with a fall of cardiac lactate extraction. The resting and CPT-induced TXB2 gradients were unrelated to the presence and severity of coronary angiographic lesions. These results indicate that unstable angina patients show an abnormal cardiocoronary capacity to synthesize TXA2, which seems not to be elicited by the occurrence of myocardial ischemia.

AB - Thromboxane B2 (TXB2), the stable metabolite of thromboxane A2 (TXA2), was measured in the coronary sinus and in aortic blood before and after cold pressor test (CPT) in 21 patients suffering from ischemic heart disease (7 affected by stable effort angina and 14 by unstable angina) and in 12 patients not suffering from myocardial ischemia (control group) during coronary angiography. Aspirin (10 mg/kg intravenously) was administered before catheterization in order to prevent platelet and leukocyte TXA2 formation. Control subjects and patients with effort angina had TXB2 resting levels lower than unstable angina patients without a transcardiac gradient which, on the contrary, was found in unstable angina patients. Only in these patients CPT resulted in a significant TXB2 increase more marked in the coronary sinus (from 50.0 ± 18.9 pg/ml to 73.0 ± 35.1 pg/ml, p <0.001) than in the aorta (from 33.4 ± 17.1 pg/ml to 42.6 ± 24.0 pg/ml, p <0.05), so that the transcardiac TXB2 gradient significantly increased. In all but two unstable angina patients, TXB2 elevation was not associated with a fall of cardiac lactate extraction. The resting and CPT-induced TXB2 gradients were unrelated to the presence and severity of coronary angiographic lesions. These results indicate that unstable angina patients show an abnormal cardiocoronary capacity to synthesize TXA2, which seems not to be elicited by the occurrence of myocardial ischemia.

UR - http://www.scopus.com/inward/record.url?scp=0021912343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021912343&partnerID=8YFLogxK

U2 - 10.1016/0002-8703(85)90631-3

DO - 10.1016/0002-8703(85)90631-3

M3 - Article

C2 - 3984828

AN - SCOPUS:0021912343

VL - 109

SP - 732

EP - 738

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 4

ER -